Venus Remedies Limited (VENUSREM) — Financial Results | 25 June 2026
Venus Remedies Limited announced that its designated insiders must remain in a trading window closure from July 1, 2026, until 48 hours after the unaudited financial results for the period ending June 30, 2026, are declared, as mandated by SEBI regulations.
About Venus Remedies Limited (VENUSREM)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when VENUSREM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track VENUSREM — Free💡 Ask AI about this filing
📊 More VENUSREM filings
- Announcement — 25 September 2026Venus Remedies announced that its insider trading window will close on September 25, 2026, following...
- share transfer — 8 September 2026Venus Remedies announced a special window for re-lodging transfer requests of physical shares via so...
- 🟡 Board Meeting — 20 August 2026Venus Remedies Limited announced board appointments and reappointments at its 37th Annual General Me...
- 🟡 Board Meeting — 20 August 2026Venus Remedies held its 37th Annual General Meeting on 20th August 2026 via video conference, where ...
- 🔴 Annual Report — 24 July 2026Venus Remedies Limited announced its 37th AGM on August 20, 2026, via video conferencing, with resol...
🔥 Also filed on 25 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when VENUSREM files new disclosures
Track VENUSREM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track VENUSREM — FreeFree account · 2 AI queries/day